Figure S16 from PKMYT1 is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer
crossref(2024)
摘要
Effect of knocking down mutant p53 and re-expressing wild-type (WT) p53 in T47D Palbo-R cells on synergy and viability to the RP-6306 and gemcitabine combination
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要